Neurochemical Research

, Volume 36, Issue 2, pp 187–194 | Cite as

Resveratrol Inhibits Proliferation and Promotes Apoptosis of Neuroblastoma Cells: Role of Sirtuin 1

  • Javier G. Pizarro
  • Ester Verdaguer
  • Virginie Ancrenaz
  • Felix Junyent
  • Francesc Sureda
  • Mercè Pallàs
  • Jaume Folch
  • Antoni Camins


Resveratrol prolongs lifespan and prevent cancer formation; however, the mechanisms are not understood. Here we evaluated the cell-cycle inhibition and apoptosis of resveratrol in B65 neuroblastoma cells, and we also studied the effects of resveratrol on the mammalian silent information regulator 2 (SIRT1). Results show that resveratrol reduces cell viability and causes apoptosis at 24 h of treatment. Resveratrol partially blocked cell proliferation, and significantly increased the fraction of cells arrested in the S phase. The role of SIRT1 in cell-cycle effects mediated by resveratrol was studied through changes in the expression of SIRT1 using western blot. Exposure to resveratrol decreased SIRT1 content, concomitant with an increase in the acetylated form of sirtuin substrates p53 and NFκ-β. Treatment of B65 neuroblastoma cells with resveratrol also reduced the content of the phosphorylated form of AKT. Exposure to the SIRT1 inhibitors nicotinamide and sirtinol altered neither cell viability nor the fraction of apoptotic cells. Furthermore, when cells were exposed simultaneously to resveratrol and nicotinamide or sirtinol, no changes were observed in the fraction of apoptotic cells. Our results show that a decrease in SIRT1 content, caused by exposure to resveratrol, does not appear to be involved in cell-cycle arrest or activation of apoptosis.


Neuroblastoma B65 Resveratrol Sirtinol Silent information regulator (SIRT1) Sirtuin 1 Caspase 3 Apoptosis 



We thank the Language Advisory Service of the University of Barcelona for revising this manuscript. This study was supported by grants SAF-2009-13093 from the Ministerio de Educación y Ciencia, PI080400 and PS09/01789 from the Instituto de Salud Carlos III, 2009/SGR00853 from the Generalitat de Catalunya and (063230) from the Fundació La Marató of TV3. 610RT0405 from programa Iberoamericano de Ciencia y Tecnologia para el Desarrollo (CYTED).


  1. 1.
    Shakibaei M, Harikumar KB, Aggarwal BB (2009) Resveratrol addiction: to die or not to die. Mol Nutr Food Res 53:115–128CrossRefPubMedGoogle Scholar
  2. 2.
    Roccaro AM, Leleu X, Sacco A et al (2008) Resveratrol exerts antiproliferative activity and induces apoptosis in Waldenström’s macroglobulinemia. Clin Cancer Res 14:1849–1858CrossRefPubMedGoogle Scholar
  3. 3.
    Pallàs M, Casadesús G, Smith MA et al (2009) Resveratrol and neurodegenerative diseases: activation of SIRT1 as the potential pathway towards neuroprotection. Curr Neurovasc Res 6:70–81CrossRefPubMedGoogle Scholar
  4. 4.
    Pallàs M, Verdaguer E, Tajes M et al (2008) Modulation of sirtuins: new targets for antiageing. Recent Pat CNS Drug Discov 3:61–69CrossRefPubMedGoogle Scholar
  5. 5.
    Jang M, Cai L, Udeani GO et al (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275:218–220CrossRefPubMedGoogle Scholar
  6. 6.
    Pozo-Guisado E, Lorenzo-Benayas MJ, Fernández-Salguero PM (2004) Resveratrol modulates the phosphoinositide 3-kinase pathway through an estrogen receptor alpha-dependent mechanism: relevance in cell proliferation. Int J Cancer 109:167–173CrossRefPubMedGoogle Scholar
  7. 7.
    Komina O, Wesierska-Gadek J (2008) Action of resveratrol alone or in combination with roscovitine, a CDK inhibitor, on cell cycle progression in human HL-60 leukemia cells. Biochem Pharmacol 76:1554–1562CrossRefPubMedGoogle Scholar
  8. 8.
    Roy P, Kalra N, Prasad S et al (2009) Chemopreventive potential of resveratrol in mouse skin tumors through regulation of mitochondrial and PI3K/AKT signaling pathways. Pharm Res 26:211–217CrossRefPubMedGoogle Scholar
  9. 9.
    Denu JM (2005) The Sir 2 family of protein deacetylases. Curr Opin Chem Biol 9:431–440CrossRefPubMedGoogle Scholar
  10. 10.
    Cucciolla V, Borriello A, Oliva A et al (2007) Resveratrol: from basic science to the clinic. Cell Cycle 6:2495–2510CrossRefPubMedGoogle Scholar
  11. 11.
    Jiang WJ (2008) Sirtuins: novel targets for metabolic disease in drug development. Biochem Biophys Res Commun 373:341–344CrossRefPubMedGoogle Scholar
  12. 12.
    Guarente L (2007) Sirtuins in aging and disease. Cold Spring Harb Symp Quant Biol 72:483–488CrossRefPubMedGoogle Scholar
  13. 13.
    Wood JG, Rogina B, Lavu S et al (2004) Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 430:686–689CrossRefPubMedGoogle Scholar
  14. 14.
    Rayalam S, Yang JY, Ambati S et al (2008) Resveratrol induces apoptosis and inhibits adipogenesis in 3T3–L1 adipocytes. Phytother Res 22:1367–1371CrossRefPubMedGoogle Scholar
  15. 15.
    Roncoroni L, Elli L, Dolfini E et al (2008) Resveratrol inhibits cell growth in a human cholangiocarcinoma cell line. Liver Int 28:1426–1436CrossRefPubMedGoogle Scholar
  16. 16.
    Li Y, Bäckesjö CM, Haldosén LA, Lindgren U (2009) Resveratrol inhibits proliferation and promotes apoptosis of osteosarcoma cells. Eur J Pharmacol 609:13–18CrossRefPubMedGoogle Scholar
  17. 17.
    Kaeberlein M, McDonagh T, Heltweg B (2005) Substrate-specific activation of sirtuins by resveratrol. J Biol Chem 280:17038–17045CrossRefPubMedGoogle Scholar
  18. 18.
    Kim YA, Choi BT, Lee YT et al (2004) Resveratrol inhibits cell proliferation and induces apoptosis of human breast carcinoma MCF-7 cells. Oncol Rep 11:441–446PubMedGoogle Scholar
  19. 19.
    Kim EJ, Kho JH, Kang MR, Um SJ (2007) Active regulator of SIRT1 cooperates with SIRT1 and facilitates suppression of p53 activity. Mol Cell 28:277–290CrossRefPubMedGoogle Scholar
  20. 20.
    Kobayashi Y, Furukawa-Hibi Y, Chen C (2005) SIRT1 is critical regulator of FOXO-mediated transcription in response to oxidative stress. Int J Mol Med 16:237–243PubMedGoogle Scholar
  21. 21.
    Rathbone CR, Booth FW, Lees SJ (2009) Sirt1 increases skeletal muscle precursor cell proliferation. Eur J Cell Biol 88:35–44CrossRefPubMedGoogle Scholar
  22. 22.
    Alvira D, Yeste-Velasco M, Folch J et al (2007) Comparative analysis of the effects of resveratrol in two apoptotic models: inhibition of complex I and potassium deprivation in cerebellar neurons. Neuroscience 147:746–756CrossRefPubMedGoogle Scholar
  23. 23.
    Cao C, Lu S, Kivlin R, Wallin B et al (2009) SIRT1 confers protection against UVB- and H2O2-induced cell death via modulation of p53 and JNK in cultured skin keratinocytes. J Cell Mol Med 13:3632–3643CrossRefPubMedGoogle Scholar
  24. 24.
    Quincozes-Santos A, Andreazza AC, Nardin P et al (2007) Resveratrol attenuates oxidative-induced DNA damage in C6 Glioma cells. Neurotoxicology 28:886–891CrossRefPubMedGoogle Scholar
  25. 25.
    Chakraborty PK, Mustafi SB, Ganguly S, Chatterjee M, Raha S (2008) Resveratrol induces apoptosis in K562 (chronic myelogenous leukemia) cells by targeting a key survival protein, heat shock protein 70. Cancer Sci 99:1109–1116CrossRefPubMedGoogle Scholar
  26. 26.
    Stefani M, Markus MA, Lin RC et al (2007) The effect of resveratrol on a cell model of human aging. Ann NY Acad Sci 1032:134–145Google Scholar
  27. 27.
    Madan E, Prasad S, Roy P, George J, Shukla Y (2008) Regulation of apoptosis by resveratrol through JAK/STAT and mitochondria mediated pathway in human epidermoid carcinoma A431 cells. Biochem Biophys Res Commun 377:1232–1237CrossRefPubMedGoogle Scholar
  28. 28.
    Wesierska-Gadek J, Kramer MP, Maurer M (2008) Resveratrol modulates roscovitine-mediated cell cycle arrest of human MCF-7 breast cancer cells. Food Chem Toxicol 46:1327–1333CrossRefPubMedGoogle Scholar
  29. 29.
    Bhardwaj G, Sethi S, Vadhan-Raj C, Bueso-Ramos Y et al (2007) Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-{kappa}B-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells. Blood 109:2293–2302CrossRefPubMedGoogle Scholar
  30. 30.
    Gatz SA, Wiesmüller L (2008) Take a break resveratrol in action on DNA. Carcinogenesis 29:321–332CrossRefPubMedGoogle Scholar
  31. 31.
    Xi J, Wang H, Mueller RA et al (2009) Mechanism for resveratrol-induced cardioprotection against reperfusion injury involves glycogen synthase kinase 3beta and mitochondrial permeability transition pore. Eur J Pharmacol 604:111–116CrossRefPubMedGoogle Scholar
  32. 32.
    Chao J, Yu MS, Ho YS et al (2008) Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity. Free Rad Biol Med 45:1019–1026CrossRefPubMedGoogle Scholar
  33. 33.
    Bradamante S, Barenghi L, Villa A (2004) Cardiovascular protective effects of resveratrol. Cardiovasc Drug Rev 22:169–188CrossRefPubMedGoogle Scholar
  34. 34.
    de Almeida LM, Leite MC, Thomazi AP et al (2008) Resveratrol protects against oxidative injury induced by H2O2 in acute hippocampal slice preparations from Wistar rats. Arch Biochem Biophys 480:27–32CrossRefPubMedGoogle Scholar
  35. 35.
    Yu W, Fu YC, Zhou XH et al (2009) Effects of resveratrol on H2O2-induced apoptosis and expression of SIRTs in H9c2 cells. J Cell Biochem 107:741–747CrossRefPubMedGoogle Scholar
  36. 36.
    Huang J, Gan Q, Han L et al (2008) SIRT1 overexpression antagonizes cellular senescence with activated ERK/S6k1 signaling in human diploid fibroblasts. PLoS One 3:e1710CrossRefPubMedGoogle Scholar
  37. 37.
    Della-Morte D, Dave KR, DeFazio RA et al (2009) Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1-uncoupling protein 2 pathway. Neuroscience 159:993–1002CrossRefPubMedGoogle Scholar
  38. 38.
    Alvira D, Yeste-Velasco M, Folch J et al (2007) Neuroprotective effects of caffeine against complex I inhibition-induced apoptosis are mediated by inhibition of the Atm/p53/E2F–1 path in cerebellar granule neurons. J Neurosci Res 85:3079–3088CrossRefPubMedGoogle Scholar
  39. 39.
    Okawara M, Katsuki H, Kurimoto E et al (2007) Resveratrol protects dopaminergic neurons in midbrain slice culture from multiple insults. Biochem Pharmacol 73:550–560CrossRefPubMedGoogle Scholar
  40. 40.
    Howitz KT, Bitterman KJ, Cohen HY et al (2003) Small molecule activators of sirtuins extends Saccharomyces cerevisiae lifespan. Nature 425:191–196CrossRefPubMedGoogle Scholar
  41. 41.
    Julien C, Tremblay V, Emond M et al (2009) Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease. J Neuropathol Exp Neurol 68:48–58CrossRefPubMedGoogle Scholar
  42. 42.
    Pallàs M, Pizarro JG, Gutierrez-Cuesta J et al (2008) Modulation of SIRT1 expression in different neurodegenerative models and human pathologies. Neuroscience 154:1388–1397CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Javier G. Pizarro
    • 1
  • Ester Verdaguer
    • 2
  • Virginie Ancrenaz
    • 1
  • Felix Junyent
    • 1
  • Francesc Sureda
    • 4
  • Mercè Pallàs
    • 1
  • Jaume Folch
    • 3
  • Antoni Camins
    • 1
  1. 1.Unitat de Farmacologia i Farmacognòsia, Institut de Biomedicina (IBUB), Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED). Facultat de FarmàciaUniversitat de Barcelona. Nucli Universitari de PedralbesBarcelonaSpain
  2. 2.Departament de Biologia Cellular, Facultat de Biologia, Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED)Universitat de BarcelonaBarcelonaSpain
  3. 3.Unitat de Bioquimica, Facultat de Medicina i Ciències de la Salut. Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas CibernedUniversitat Rovira i VirgiliReusSpain
  4. 4.Unitat de Farmacología, Centros de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), Facultat de Medicina i Ciències de la SalutUniversitat Rovira i VirgiliReusSpain

Personalised recommendations